HWM
BIIB icon

HB Wealth Management’s Biogen BIIB Stock Holding History

HB Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.33M Buy
6,176
+495
+9% +$94.7K 0.01% 622
2026
Q1 		$1.04M Buy
5,681
+1,011
+22% +$186K 0.01% 645
2025
Q4 		$822K Buy
4,670
+581
+14% +$94.9K 0.01% 699
2025
Q3 		$573K Buy
4,089
+1,377
+51% +$186K ﹤0.01% 802
2025
Q2 		$341K Buy
2,712
+303
+13% +$37.8K ﹤0.01% 889
2025
Q1 		$330K Buy
2,409
+820
+52% +$117K ﹤0.01% 925
2024
Q4 		$243K Buy
1,589
+213
+15% +$35.9K ﹤0.01% 897
2024
Q3 		$267K Sell
1,376
-607
-31% -$127K ﹤0.01% 792
2024
Q2 		$460K Buy
1,983
+338
+21% +$73.5K 0.01% 567
2024
Q1 		$355K Buy
1,645
+237
+17% +$55.5K ﹤0.01% 600
2023
Q4 		$364K Sell
1,408
-252
-15% -$61.9K 0.01% 541
2023
Q3 		$427K Buy
1,660
+194
+13% +$51.9K 0.01% 473
2023
Q2 		$418K Buy
1,466
+81
+6% +$24.1K 0.01% 462
2023
Q1 		$385K Buy
1,385
+154
+13% +$42.6K 0.01% 475
2022
Q4 		$341K Sell
1,231
-55
-4% -$15.5K 0.01% 487
2022
Q3 		$343K Buy
+1,286
New +$273K 0.01% 412

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

HB Wealth Management's BIIB Position: Q2 2026 in Review

HB Wealth Management increased its Biogen (BIIB) stake by 8.7% in Q2 2026, buying an estimated $94.7K and bringing the position to 6,176 shares worth $1.33M. The position accounts for 0.01% of the portfolio, ranked #622.

HB Wealth Management first reported a position in BIIB in Q3 2022 and has held it in 16 quarters since. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • HB Wealth Management held 6,176 shares of Biogen worth $1.33M as of Q2 2026.
  • HB Wealth Management bought 495 Biogen shares in Q2 2026, an estimated $94.7K.
  • Biogen made up 0.01% of HB Wealth Management's portfolio in Q2 2026, its #622 holding.
  • HB Wealth Management first reported a position in Biogen in Q3 2022 and has held it in 16 quarters since.
  • 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on HB Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.